Inclisiran for hyperlipidemias

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Aug 2025: Trial registered, NCT07102628
  2. 3 Oct 2025: Trial started, NCT07102628

The trials

NCT07102628: Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

State
Under way
Phase
Phase 3
People
305 taking part
Started
3 Oct 2025
Primary completion
16 Jan 2027
Arms
Inclisiran sodium 300 mg s.c. + Standard treatment
Results
None posted
  1. 4 Aug 2025: Trial registered
  2. 3 Oct 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Leqvio.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.